Beth Hecht
CIK 1652410 · See Remarks · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.01M
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | See Remarks | 1,176,506 | $6.79 | $7.99M | -$1.06M | 27 | 2026-06-02 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 18,839 | $0.03 | $565 | $0 | 6 | 2023-06-15 |
| AYTU | Director | 9,052 | $2.15 | $19.5K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | 0 | $1.15 | $0 | $0 | 7 | 2021-03-19 |
Recent Filings · Page 4 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-02 | XERS | Grant (A) | +45,000 | $0 | EDGAR |
| 2020-02-18 | XERS | Buy (P) | +4,000 | $16.6K | EDGAR |
| 2020-01-06 | XERS | Grant (A) | +459 | $2.7K | EDGAR |
| 2019-09-12 | XERS | — | — | $0 | EDGAR |
| 2019-07-03 | XERS | Grant (A) | +1,124 | $10.9K | EDGAR |
| 2019-06-17 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-22 | XERS | Buy (P) | +2,500 | $25.0K | EDGAR |
| 2019-02-01 | XERS | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-05 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.